PW02 - Best Practices for Antibiotic Stewardship Programs ($)

Tuesday, October 18, 2022

7:50 AM – 4:00 PM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Sarah Parker, MD

Professor, Medical Director, Antimicrobial Stewardship Program
Children's Hospital Colorado/University of Colorado School of Medicine
Aurora, CO, United States

Disclosure(s): No financial relationships to disclose
Erin McCreary, PharmD

Clinical Assistant Professor, Director of Infectious Diseases Improvement and Clinical Research Innovation
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States

Disclosure(s): AbbVie Inc: Advisor/Consultant (Ongoing); Cidara Therapeutics Inc.: Advisor/Consultant (Ongoing); Entasis Pharmaceuticals: Advisor/Consultant (Ongoing); Ferring/Rebiotix Pharmaceuticals: Advisor/Consultant (Ongoing); La Jolla Pharmaceuticals: Advisor/Consultant (Ongoing); Merck and Company, Inc.: Advisor/Consultant (Ongoing); Shionogi & Co.,Ltd.: Advisor/Consultant (Ongoing); Summit pharmaceuticals: Advisor/Consultant (Ongoing)
Payal Patel, MD, MPH

Dr.
Intermountain Healthcare
Ann Arbor, MI, United States

Disclosure(s): Qiagen: Honoraria (Terminated)

Faculty(s)

Priya Nori, MD, FSHEA, FIDSA

Priya Nori, MD
Montefiore Medical Center
Bronx, NY, United States

Disclosure(s): No financial relationships to disclose

Slides
Stephanie Shealy May, PharmD

Infectious Diseases and Antimicrobial Stewardship Telehealth Pharmacist
Intermountain Healthcare
Salt Lake City, UT, United States

Disclosure(s): No financial relationships to disclose
Nicholas Torney, PharmD, BCPS, BCPID

Infectious Diseases/Antimicrobial Stewardship Pharmacist
Munson Medical Center
Traverse City, MI, United States

Disclosure(s): No financial relationships to disclose
Elitza Theel, PhD, D(ABMM)

Director, Infectious Diseases Serology Laboratory
Laboratory Medicine and Pathology
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()

Slides
Pranita Tamma, MD, MHS

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland, United States

Disclosure(s): No financial relationships to disclose

Slides
MARC Meyer, BPharm, RPh, CIC FAPIC

Director of Pharmacy and Infection Prevention
Southwest Health System, CO, United States

Disclosure(s): No financial relationships to disclose
AH

Amanda Hurst

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Alex Trzebucki, MD

Clinical Assistant Professor of Medicine
Department of Medicine / University of Pittsburgh School of Medicine
Pittsburgh, PA, United States

Disclosure(s): No financial relationships to disclose
Ryan Shields, PharmD, MS

Associate Professor of Medicine
Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania, United States

Disclosure(s): No financial relationships to disclose

Slides
Sonja Ziniel, PhD, MA

Associate Professor
Pediatrics
University of Colorado School of Medicine/Children's Hospital Colorado
Aurora, Colorado, United States

Disclosure(s): No financial relationships to disclose

Slides
SA

Samuel Aitken, PharmD

The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Disclosure(s): Entasis Therapeutics: Advisor/Consultant (Ongoing); Glaxo Smith Kline: Advisor/Consultant (Ongoing); Melinta: Grant/Research Support (Ongoing); Shionogi: Advisor/Consultant (Ongoing)

Slides
Ghady Haidar, MD

Assistant Professor of Medicine
University of Pittsburgh School of Medicine
Pittsburg, PA, United States

Disclosure(s): Karius, Allovir, and AstraZeneca: Grant/Research Support (Ongoing); Karius, AstraZeneca: Advisor/Consultant (Ongoing); MDOutlook: Honoraria (Terminated); NIH/NIAID: Grant/Research Support (Ongoing)

Slides

Disclosure(s):

Sarah K. Parker, MD: No financial relationships to disclose

Erin K. McCreary, PharmD: AbbVie Inc: Advisor/Consultant (Ongoing); Cidara Therapeutics Inc.: Advisor/Consultant (Ongoing); Entasis Pharmaceuticals: Advisor/Consultant (Ongoing); Ferring/Rebiotix Pharmaceuticals: Advisor/Consultant (Ongoing); La Jolla Pharmaceuticals: Advisor/Consultant (Ongoing); Merck and Company, Inc.: Advisor/Consultant (Ongoing); Shionogi & Co.,Ltd.: Advisor/Consultant (Ongoing); Summit pharmaceuticals: Advisor/Consultant (Ongoing)

Payal K. Patel, MD, MPH: Qiagen: Honoraria (Terminated)

Priya Nori, MD, FSHEA, FIDSA: No financial relationships to disclose

Stephanie Shealy May, PharmD: No financial relationships to disclose

Nicholas Torney, PharmD, BCPS, BCPID: No financial relationships to disclose

Elitza Theel, PhD, D(ABMM): Euroimmun US: Advisor/Consultant (); Oxford Immunotech: Advisor/Consultant (); Roche Diagnostics: Advisor/Consultant (); Serimmune Inc: Advisor/Consultant ()

Pranita Tamma, MD, MHS: No financial relationships to disclose

MARC J. Meyer, BPharm, RPh, CIC FAPIC: No financial relationships to disclose

Alex Trzebucki, MD: No financial relationships to disclose

Ryan K. Shields, PharmD, MS: No financial relationships to disclose

Sonja I. Ziniel, PhD, MA: No financial relationships to disclose

Samuel L. Aitken, PharmD: Entasis Therapeutics: Advisor/Consultant (Ongoing); Glaxo Smith Kline: Advisor/Consultant (Ongoing); Melinta: Grant/Research Support (Ongoing); Shionogi: Advisor/Consultant (Ongoing)

Ghady Haidar, MD: Karius, Allovir, and AstraZeneca: Grant/Research Support (Ongoing); Karius, AstraZeneca: Advisor/Consultant (Ongoing); MDOutlook: Honoraria (Terminated); NIH/NIAID: Grant/Research Support (Ongoing)

CME Credits: Maximum of 7.5 hours of AMA PRA Category 1 Credit™
No MOC Points Offered
CNE Credits: Maximum of 7.5 hours of ANCC Credit
ACPE Credits: ACPE 7.5 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

evaluate components of effective antimicrobial stewardship programs and implement interventions in various health care settings;
review and apply strategies for and implementing process and outcomes measures;
apply antimicrobial stewardship interventions for unique populations, including outpatient settings, long-term care facilities, and pediatric populations;
critically assess available data, including pharmacy and microbiology data, and informatics strategies needed to support antimicrobial stewardship in their institution;
describe recent antimicrobial stewardship literature that could optimize their antimicrobial stewardship program;

Presentations:

7:50 AM – 8:00 AM US ET

Introductions and Welcome
8:00 AM – 8:50 AM US ET

Microbiology Nudges for Stewardship: Do You Suppress Cephs for AmpC bugs? What Do You Do If You Don’t Have Updated FQ Breakpoints? Comments on MRSA PCR Results? And More!
Workshop Speaker: Priya Nori, MD, FSHEA, FIDSA – Montefiore Medical Center
8:50 AM – 10:15 AM US ET

Stewardship in Under Explored Settings
Workshop Speaker: MARC J. Meyer, BPharm, RPh, CIC FAPIC – Southwest Health System
Workshop Speaker: Amanda Hurst
Workshop Speaker: Alex Trzebucki, MD – Department of Medicine / University of Pittsburgh School of Medicine
Workshop Speaker: Stephanie Shealy May, PharmD – Intermountain Healthcare
Workshop Speaker: Nicholas Torney, PharmD, BCPS, BCPID – Munson Medical Center
10:30 AM – 11:30 AM US ET

Pro-Con Debate: FQ Prophy in HCT
Workshop Speaker: Samuel L. Aitken, PharmD – The University of Texas MD Anderson Cancer Center
Workshop Speaker: Ghady Haidar, MD – University of Pittsburgh School of Medicine
11:30 AM – 12:30 PM US ET

Pseudomonas aeruginosa and Enterobacter cloacae: Our Unsung Nemeses
Workshop Speaker: Pranita Tamma, MD, MHS – Johns Hopkins School of Medicine
Workshop Speaker: Ryan K. Shields, PharmD, MS – University of Pittsburgh
1:45 PM – 2:25 PM US ET

Surveys to Measure Stewardship Success
Workshop Speaker: Sonja I. Ziniel, PhD, MA – University of Colorado School of Medicine/Children's Hospital Colorado
2:25 PM – 3:40 PM US ET

Labs and Cultures We Do for No Good Reason
Workshop Speaker: Alex Trzebucki, MD – Department of Medicine / University of Pittsburgh School of Medicine
Workshop Speaker: Elitza Theel, PhD, D(ABMM) – Mayo Clinic
3:40 PM – 4:00 PM US ET

Thank Yous and Wrap Up